Ruth Saganty

Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms

M. Ladanyi, M. Berger, A. Drilon, 2019, Nature Medicine.

Activating mutations in CSF-1R and additional receptor tyrosine kinases in histiocytic neoplasms

M. Ladanyi, M. Berger, A. Drilon, 2019, Nature Medicine.

Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade

P. Hsu, P. Zhang, Junfei Zhao, 2023, Nature Communications.

Advances in Blood-Brain Barrier Disruption to Facilitate Drug Delivery for Infiltrative Gliomas.

R. Stupp, A. Heimberger, A. Sonabend, 2023, Advances in oncology.